Comparison tool
Argireline vs GHK-Cu side-by-side
Stack up to four peptides by evidence status, mechanisms, study dosing, side effects, and references.
Comparison tool
Stack up to four peptides by evidence status, mechanisms, study dosing, side effects, and references.
Selected (2/4)
Share this peptide comparison
| Property | Argireline | GHK-Cu |
|---|---|---|
| Category | Skin & Hair | Skin & Hair |
| Also known as | Acetyl Hexapeptide-3, Acetyl Hexapeptide-8 | Copper Peptide, Glycyl-L-histidyl-L-lysine copper |
| FDA approved | No | No |
| Clinical status | Cosmetic use - widely available
| Used in cosmetic products with limited human topical-skincare evidence; the source also notes injectable compounding restrictions and a pending reclassification process.
|
| What to expect | Wrinkle reduction, forehead lines, eye area anti-aging | Skin rejuvenation, wound healing, hair growth, anti-aging |
| How it works | Argireline is described as an acetyl hexapeptide-8 fragment connected to SNAP-25, a protein involved in the SNARE machinery for acetylcholine release. The source reports that early laboratory work found neurotransmitter-release inhibition in cell systems. A key limitation is topical delivery: the supplied review summary notes disagreement about skin penetration and states that in vivo demonstration of the marketed muscle-inhibition mechanism was not shown. | GHK-Cu is described as the copper(II) complex of the GHK tripeptide. The source connects its activity to copper binding and possible cellular copper delivery, but also emphasizes effects that go beyond a simple carrier model. Reported laboratory observations include shifts in gene expression, increased fibroblast production of extracellular-matrix components, keratinocyte support, vascular-related activity, and antioxidant or anti-inflammatory signals. The precise mechanism is still not fully defined. |
| Typical dosing | Limited community data available · See research protocols | 1-2 mg daily injection or 0.05% topical · Once daily · Subcutaneous injection or topical application |
| Research dosing | 5-10% concentration in formulations · Ongoing use for maintained effects · Topical (serums, creams) | 1-2 mg for injectable protocols · Varies by application · Subcutaneous injection or topical application |
| Typical duration | Ongoing use for maintained effects | Varies by application |
| Administration | Topical (serums, creams) | Subcutaneous injection or topical application |
| Timing | Morning and evening (topical) With or without food | Evening for skin or recovery contexts With or without food |
| Evidence level | Research | Clinical Trials |
| Possible side effects |
+1 more
|
+4 more
|
| Research summary | The source summary cites a 2002 Blanes-Mira study using a 10% peptide oil-in-water emulsion and reporting a 30% wrinkle-depth reduction, alongside cell-assay support for SNARE interference. It also describes a small double-blind split-face study in 19 women where four weeks of Argireline serum did not significantly outperform placebo by VISIA imaging and was not considered a botulinum toxin substitute. A 2025 review is reported to have found inconsistent penetration estimates, about 30% stratum-corneum passage in one study versus about 0.2% in another, and no in vivo proof of the proposed muscle-inhibition mechanism. Overall, the supplied evidence frames Argireline as a plausible cosmetic peptide with limited and mixed human data, while noting no serious adverse effects reported. | The source describes a mixed evidence base. Cell and animal work is reported for wound repair, collagen deposition, fibroblast activity, elastin and growth-factor production, keratinocyte protection, and lung-injury models. Human data are described as small topical cosmetic studies, including facial-cream and eye-cream studies with 71 and 41 participants that reported changes in skin density, thickness, and wrinkle appearance. These data are encouraging for topical skin endpoints but do not establish injected or systemic benefits. |
| References | ||
| Full profile | View Details | View Details |
Save this comparison
Keep this research set handy with a free PeptiGuide account.
Save this comparison - free accountTrack your peptide journey
Turn research into a private protocol log when you are ready.
Track your peptide journeyEducational use only. This information is aggregated from public research and community reports. It is not medical advice, and dosing details are descriptive, not recommendations. Always consult a qualified healthcare professional.